Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - OTC Markets Other stock markets 19:47:35 08/04/2026 BST			5-day change	1st Jan Change
0.5320 ^USD	+66.25%		-.--%	+66.25%

07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT

Market Cap	48.98M 56.04M 45.3M 41.57M 78.67M 5.4B 80.04M 540M 212M 2.64B 210M 206M 9.1B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	56.83M 65.02M 52.56M 48.23M 91.28M 6.27B 92.87M 627M 246M 3.06B 244M 239M 10.56B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
05-11	Theraclion raises nearly 6 million euros via units with warrants

07-15	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
06-04	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU

Theraclion Share Price OTC Markets

Stocks

TCLIF

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Income Statement and Estimates

Annual profits - Rate of surprise

07-15	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
06-19	Les puces américaines en weekend prolongé

Current year	0.53	0.53
1 year	0.53	0.53
3 years	0	0.59
5 years	0	2.28
10 years	0	2.6

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	23/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	31/01/2018
Ari Kellen BRD	Director/Board Member	-	12/02/2019
Shawn Langer BRD	Director/Board Member	-	12/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+66.25%	-.--%	-	-	56.03M
THERMO FISHER SCIENTIFIC, INC.	+1.48%	+3.52%	+30.48%	+3.41%	199B
DANAHER CORPORATION	+2.10%	+4.61%	+6.06%	-13.77%	142B
INTUITIVE SURGICAL, INC.	+3.43%	-2.24%	-21.52%	+13.70%	138B
BOSTON SCIENTIFIC CORPORATION	+3.67%	-0.82%	-56.76%	-15.19%	63.97B
EDWARDS LIFESCIENCES CORPORATION	+0.65%	-3.82%	+15.37%	-5.19%	50.25B
SIEMENS HEALTHINEERS AG	+1.18%	+2.66%	-23.86%	-31.97%	44.33B
AGILENT TECHNOLOGIES, INC.	+1.03%	+1.88%	+19.99%	+15.10%	38.05B
WATERS CORPORATION	+0.87%	+0.28%	+30.61%	+40.16%	36.81B
GE HEALTHCARE TECHNOLOGIES INC.	+3.96%	+1.55%	-12.92%	-19.08%	28.75B
Average	+7.13%	-0.50%	-1.40%	-1.43%	82.33B
Weighted average by Cap.	-0.09%	+0.18%	+2.10%	-0.72%

	2024	2025
Net sales	830K 950K 768K 705K 1.33M 91.52M 1.36M 9.16M 3.6M 44.69M 3.57M 3.49M 154M	652K 746K 603K 553K 1.05M 71.88M 1.07M 7.19M 2.82M 35.1M 2.8M 2.74M 121M
Net income	-5.76M -6.59M -5.32M -4.89M -9.25M -635M -9.41M -63.5M -24.94M -310M -24.73M -24.19M -1.07B	-5.69M -6.51M -5.26M -4.83M -9.14M -627M -9.3M -62.76M -24.65M -306M -24.45M -23.91M -1.06B
Net Debt	3.41M 3.9M 3.15M 2.89M 5.48M 376M 5.57M 37.62M 14.78M 184M 14.65M 14.33M 634M	7.85M 8.98M 7.26M 6.66M 12.61M 866M 12.83M 86.6M 34.02M 423M 33.73M 32.99M 1.46B